Skip to main content

Pardes Biosciences, Inc.

PRDSDelisted Aug 31, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001822711

Pardes Biosciences, Inc. was delisted on Aug 31, 2023; its insiders filed their last Form 4 on Aug 31, 2023; 59 institutions reported holding it in 13F filings for Q2 2023, worth $63.9M in total; no superinvestor held it.

Q2 2023 vs. Q1 2023

How the institutions holding Pardes Biosciences, Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of PRDS: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders6059−1
Shares36.8M35.3M−1.52M (−4.1%)
Value$48.6M$63.9M+$15.3M (+31.5%)

New holders (17)

Institutions that held Pardes Biosciences, Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to PRDS in Q2 2023
InstitutionSharesValue% of portfolio
Western Standard LLC482,874$874.0K0.76%
Acuitas Investments, LLC266,061$481.6K0.28%
Terrapin Asset Management, LLC244,550$442.6K0.62%
RBF Capital, LLC150,000$271.5K0.02%
Cowen and Company, LLC76,839$139.1K0.01%
Marquette Asset Management, LLC54,278$98.2K0.02%
Irenic Capital Management LP48,751$88.2K0.03%
Qube Research & Technologies Ltd47,664$86.3K0.00%
Y-Intercept (Hong Kong) Ltd47,469$85.9K0.01%
JBF Capital, Inc.43,998$79.6K0.02%
Jane Street Group, LLC20,076$36.3K0.00%
Cubist Systematic Strategies, LLC13,120$23.7K0.00%
Citadel Advisors LLC12,262$22.2K0.00%
Squarepoint Ops LLC12,211$22.1K0.00%
Point72 Middle East FZE4,501$8.15K0.00%
Federated Hermes, Inc.2,677$4.84K0.00%
Point72 Asset Management, L.P.41$740.00%

Sold out (18)

Institutions that held Pardes Biosciences, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.